nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
1 |
A biomarker-stratified comparison of top-down versus accelerated step-up treatment strategies for patients with newly diagnosed Crohn's disease (PROFILE): a multicentre, open-label randomised controlled trial
|
Noor, Nurulamin M |
|
|
9 |
5 |
p. 415-427 |
artikel |
2 |
Addressing the evolving landscape of global malnutrition
|
The Lancet Gastroenterology & Hepatology, |
|
|
9 |
5 |
p. 393 |
artikel |
3 |
A women-focused matrix mentorship programme in gastroenterology
|
Devi, Jalpa |
|
|
9 |
5 |
p. 405-407 |
artikel |
4 |
ECCO'24
|
Gomersall, Bethany |
|
|
9 |
5 |
p. 413 |
artikel |
5 |
Effect of robotic versus open pancreaticoduodenectomy on postoperative length of hospital stay and complications for pancreatic head or periampullary tumours: a multicentre, open-label randomised controlled trial
|
Liu, Qu |
|
|
9 |
5 |
p. 428-437 |
artikel |
6 |
Fine-tuning the gut ecosystem: the current landscape and outlook of artificial microbiome therapeutics
|
Porcari, Serena |
|
|
9 |
5 |
p. 460-475 |
artikel |
7 |
Has the time come for a systematic top-down approach in Crohn's disease?
|
Fumery, Mathurin |
|
|
9 |
5 |
p. 394-395 |
artikel |
8 |
Local ablation in pancreatic cancer: some answers and more questions
|
Berman, Zachary T |
|
|
9 |
5 |
p. 398-400 |
artikel |
9 |
Microbiota therapeutics for inflammatory bowel disease: the way forward
|
Bethlehem, Lukas |
|
|
9 |
5 |
p. 476-486 |
artikel |
10 |
MRI-guided stereotactic ablative body radiotherapy versus CT-guided percutaneous irreversible electroporation for locally advanced pancreatic cancer (CROSSFIRE): a single-centre, open-label, randomised phase 2 trial
|
Timmer, Florentine E F |
|
|
9 |
5 |
p. 448-459 |
artikel |
11 |
NORPACT-1: implications for future trials
|
Snyder, Rebecca A |
|
|
9 |
5 |
p. 408 |
artikel |
12 |
NORPACT-1: implications for future trials – Authors' reply
|
Labori, Knut Jørgen |
|
|
9 |
5 |
p. 408-409 |
artikel |
13 |
Prophylactic abdominal drainage after distal pancreatectomy (PANDORINA): an international, multicentre, open-label, randomised controlled, non-inferiority trial
|
van Bodegraven, Eduard A |
|
|
9 |
5 |
p. 438-447 |
artikel |
14 |
Research in Brief
|
Baker, Holly |
|
|
9 |
5 |
p. 414 |
artikel |
15 |
Robotic pancreatoduodenectomy: preparing for the future
|
Bannone, Elisa |
|
|
9 |
5 |
p. 395-397 |
artikel |
16 |
Should a no-drain policy after distal pancreatectomy become standard?
|
Klaiber, Ulla |
|
|
9 |
5 |
p. 397-398 |
artikel |
17 |
Top ten research priorities for alcohol use disorder and alcohol-related liver disease: results of a multistakeholder research priority setting partnership
|
Subhani, Mohsan |
|
|
9 |
5 |
p. 400-402 |
artikel |
18 |
Use of immunomodulators in combination with infliximab in Crohn's disease: time for a reappraisal?
|
Chapman, Thomas P |
|
|
9 |
5 |
p. 402-405 |
artikel |
19 |
US Government, states reign in insurers' prior authorisation
|
Furlow, Bryant |
|
|
9 |
5 |
p. 411-412 |
artikel |
20 |
Validating the new nomenclature of steatotic liver disease in patients with excessive alcohol intake
|
Wu, Yu |
|
|
9 |
5 |
p. 409 |
artikel |
21 |
Validating the new nomenclature of steatotic liver disease in patients with excessive alcohol intake – Authors' reply
|
Israelsen, Mads |
|
|
9 |
5 |
p. 409-410 |
artikel |